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The study aimed to investigate the effects of differentiated exercise regimes on high fat-induced metabolic and inflammatory
pathways.Mice were fed a standard diet (ST) or a high fat diet (HFD) and subjected to regular endurance training (ET) or resistance
training (RT). After 10 weeks bodyweight, glucose tolerance, fatty acids (FAs), circulating ceramides, cytokines, and immunological
mediatorswere determined.TheHFD induced a significant increase in bodyweight and a disturbed glucose tolerance (𝑝 < 0.05). An
increase of plasma FA, ceramides, and inflammatory mediators in adipose tissue and serum was found (𝑝 < 0.05). Both endurance
and resistance training decreased body weight (𝑝 < 0.05) and reduced serum ceramides (𝑝 < 0.005). While RT attenuated the
increase of NLRP-3 (RT) expression in adipose tissue, ET was effective in reducing TNF-𝛼 and IL-18 expression. Furthermore,
ET reduced levels of MIP-1𝛾, while RT decreased levels of IL-18, MIP-1𝛾, Timp-1, and CD40 in serum (𝑝 < 0.001), respectively.
Although both exercise regimes improved glucose tolerance (𝑝 < 0.001), ET was more effective than RT. These results suggest
that exercise improves HFD-induced complications possibly through a reduction of ceramides, the reduction of inflammasome
activation in adipose tissues, and a systemic downregulation of inflammatory cytokines.
1. Introduction
Obesity is often associated with a systemic low grade
inflammation [1]. One of the prominent hallmarks of
obesity-induced inflammation is a shift in the phenotype
of macrophage and T-cell populations present in adipose
tissue (AT) reflecting in a unique set of pro- and anti-
inflammatory cytokines [2]. Free fatty acids and saturated
fatty acids (SFA) are suggested to induce inflammation by
activation of Toll-like receptors (TLRs) 4 and 2 in adipose
tissue and macrophages, culminating in an increased
activation of nuclear factor kappa-B (NF-𝜅B) thus increasing
the expression in proinflammatory cytokines like TNF-𝛼 or
IL-6 [2, 3]. Apart from SFA, a deregulated ceramide synthesis
has also been suggested to play an important role in obesity
related inflammation [4, 5].
Aerobic exercise is known to have triglyceride-lowering
effects accompanied by a reduction of visceral and abdominal
adipose tissue in overweight and obese subjects [6, 7].
These metabolic effects of exercise training are regularly
accompanied by a reduction of the inflammatory status [8, 9].
Thereby, exercise training was followed by a reduced expres-
sion of both TLRs and several proinflammatory cytokines
[9, 10]. However, most studies on exercise effects on obesity
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investigated the effect of aerobic/endurance training [3, 11].
Resistance training received less attention, but there are
several evidences that it also affects metabolic disorders and
inflammation in obesity [12–16].
Insulin resistance is a common complication of obesity-
induced inflammation and the reduction of blood glu-
cose a desirable outcome of weight loss programs [17]. In
recent years, the nucleotide-binding domain and leucine-
rich-repeat and pyrin domain containing 3 (NLRP-3) inflam-
masome has been identified as a major contributor to the
development of systemic inflammation and insulin resistance
[18]. NLRP-3 assembly is initiated upon TLR activation,
extracellular ATP, or active interleukin 1𝛽 (IL-1𝛽). Expression
of proIL-1𝛽 and proIL-18 is NF-𝜅B dependent which in turn
depends on activation through TNF-𝛼. The maturation of
NLRP-3 renders caspase 1 active that cleaves inactive proIL-1𝛽
and proIL-18 into their active forms which are then secreted
into the surrounding tissue [18].
It was also found that ceramides induced the NLRP-3
inflammasome, driving the secretion of IL-1𝛽 followed
by the development of insulin resistance [18]. Ceramides
induce insulin resistance through the dephosphorylation
of serine/threonine kinase Akt/PKB, hence disabling the
translocation of GLUT4 to the cell membrane and reducing
the uptake of glucose [19–21]. Aerobic exercise reduced
ceramides in humans and ceramidase activity in rat skeletal
muscle [22]. However, the effects of differentiated exercise
regimes on ceramide levels, AT inflammation, and systemic
cytokine levels in mice have so far not been investigated
in one cohesive study. Therefore, we investigated whether
different exercise regimes affect glucose tolerance, serum
fatty acids and ceramides, inflammatory parameters in
AT, and several inflammatory cytokines in serum of HFD
fed mice. We hypothesized that both types of exercise are
effective in reducing glucose intolerance. Moreover, these
effects might be achieved most likely via modifying serum
ceramide levels as well as local and systemic inflammatory
markers. Endurance and resistance training differ in their
muscle fiber response.Whereas endurance training addresses
mainly type I and type IIA muscle fibers, resistance training
is followed by a hypertrophy of types II and IIX [23, 24].
Finally, it is suggested that endurance and resistance exercise
might address different targets of these pathophysiological
signaling cascades. Therefore, a differentiated effect of
endurance and resistance training would be expected.
2. Material and Methods
2.1. Animals, Diets, and Experimental Design. Male C57BL/6
mice (𝑛 = 36), 10 weeks of age, were kept at 21 ± 1∘C in
a reverse dark-light cycle (light on from 9 pm to 9 am).
Mice were randomly assigned to 6 groups (5 to 8 mice
per group): standard chow/sedentary (ST/S, Altromin 1320,
Altromin Spezialfutter GmbH & Co., Germany), standard
chow/endurance training (ST/ET), standard chow/resistance
training (ST/RT), high fat/sedentary (HFD/S, TD 03584,
Harlan Teklad, Germany), high fat/endurance training
(HFD/ET), and high fat/resistance training (HFD/RT).
Table 1: Fatty acid composition of standard (low fat) diet and high
fat diet.
Fatty acid ST HFD
mg/kg mg/kg
10:0 — 350
12:0 — 350
14:0 — 5250
16:0 2236 64580
16:1 — 6650
17:0 — 1400
18:0 688 63000
18:1 (n-9) 3956 127750
18:2 (n-6) 9366 39550
18:3 (n-3) 1282 3150
20:0 — 1050
20:1 (n-9) — 4200
20:2 (n-6) — 1750
20:4 (n-6) — 700
ST: standard diet; HFD: high fat diet. —: not added.
The assigned diet was fed for 4 weeks before exercise
protocols were implemented. Briefly, the ST diet contained
3.4% lipids and the HFD 35% by weight. A more detailed
specification of the fatty acid composition can be found in
Table 1. Mice were caged separately, with free ad libitum
access to food and water. The animals were put on their diet
4 weeks before the 10-week exercise protocols commenced,
which means a total of 14 weeks on the diet. Weight was
recorded before and after 14 weeks on the diet. The animals
were handled according to the Guide for the Care and Use of
Laboratory Animals. The experimental design was approved
by the AnimalWelfare Officer of the Justus-Liebig-University
and the regional council of the city of Giessen (number
94/2010).
2.2. Determination of Endurance Capacity and Exercise Pro-
tocols. Before ET commenced, VO
2
max was determined for
each individual animal as described previously [25]. Eighty
percent VO
2
max was used as threshold for the following
exercise protocol. Each mouse assigned to the endurance
group was trained on an electrical treadmill (custom-made)
at 80% VO
2
max for 30min/day, 5 times/week for 10 weeks.
Briefly, by using a treadmill spiroergometry (custom-made),
maximal oxygen uptake (VO
2
max) and maximal running
speed (Vmax) of mice were determined. The treadmill was
placed in a metabolic chamber where air was led through
at a rate of 0.5 L/min. Samples of 200mL/min of gas were
extracted to the paramagnetic oxygen analyzer (type 1155,
Servomex) and the carbon dioxide analyzer (Lair 12, M&C
Instrument). All animals were acclimated to the treadmill
before VO
2
max and Vmax were tested during a continuous,
progressive test on the treadmill ergometer until exhaustion.
After 10min of acclimatization in the treadmill chamber the
test uptake started at 0.15m/s, increasing every 3min by
0.05m/s. The protocol for the resistance has recently been
published [26]. Isometric strength training was performed by
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the following experimental setup.Themice grippedwith their
front and their back paws on a horizontal wire of the metal
mesh and the plate was placed in a vertical position. The ori-
entation of the mice was holding head up. Strength training
was performed for 5 times/week for 3 minutes and 3 series.
Break between each series was 1 minute. It was previously
demonstrated that this type of isometric strength trainingwas
followed by an increase of maximum holding time in isomet-
ric strength test, a type II fiber hypertrophy, and an increased
GLUT4 protein content in the membrane fraction [26].
2.3. Glucose Tolerance Test (GTT). Glucose tolerance tests
were performed at the end of the 10-week experimental
period as follows: after an overnight 12-hour fast, blood
was drawn from the tail vein of all animals (approximately
10 𝜇L) and glucose concentration measured (glucometer,
Roche Diagnostics, Mannheim, Germany). The last training
occurred three days before GTT was performed. This was
designated as time point zero of the GTT. Glucose (2 g/kg)
was applied to the mice via intraperitoneal injection [27].
Blood glucose measurements were repeated after 30, 60, and
120min.
2.4. Tissue Samples and Sample Preparation. Mice were euth-
anized by 5% isoflurane anesthesia followed by cervical dislo-
cation.The animals were in the fed state when theywere euth-
anized. Blood was collected in EDTA-coated tubes (Sarstedt,
Germany) by cardiac puncture with heparin solution-washed
27G syringes (Sarstedt, Germany) and centrifuged for 10min
at 4∘C and 1200×g. Plasma was stored at −80∘C until fur-
ther analysis. AT surrounding mesenteric lymph nodes was
removed immediately after euthanasia and stored at −80∘C.
We used real-time quantitative PCR to determine TNF-𝛼,
NLRP-3, IL-1𝛽, and IL-18 in isolated AT.The plasmawas used
for a multiplex ELISA approach (Mouse Inflammation MAP,
Myriad RBM, Germany) as well as for determining circulat-
ing total fatty acids and ceramides. Serum was tested for the
following cytokines: CD40 (CD40), CD40 Ligand (CD40-
L), C-reactive protein (CRP), endothelin-1 (ET-1), eotaxin,
epidermal growth factor mouse (EGFmouse), factor VII, fib-
rinogen, fibroblast growth factor 9 (FGF-9), fibroblast growth
factor basic (FGF-basic), granulocyte chemotactic protein-
2 mouse (GCP-2 mouse), macrophage colony-stimulating
factor (M-CSF), growth-regulated alpha protein (KC/GRO),
haptoglobin, immunoglobulin A (IgA), interferon gamma
(IFN-gamma), interferon gamma-induced protein 10 (IP-10),
interleukin- (IL-) 1 alpha (IL-1 alpha), IL-1 beta, IL-10, IL-
11, IL-12 subunit p70 (IL-12p70), IL-17A, L-18, IL-2, IL-3, IL-
4, IL-5, IL-6, IL-7, leukemia inhibitory factor (LIF), lym-
photactin, macrophage colony-stimulating factor-1 (M-CSF-
1), macrophage inflammatory protein-1 alpha (MIP-1 alpha),
macrophage inflammatory protein-1 beta (MIP-1 beta),
macrophage inflammatory protein-1 gamma (MIP-1 gamma),
macrophage inflammatory protein-2 (MIP-2), macrophage
inflammatory protein-3 beta (MIP-3 beta), macrophage-
derived chemokine (MDC), matrix metalloproteinase 9
(MMP9), monocyte chemotactic protein-1 (MCP-1), mono-
cyte chemotactic protein 3 (MCP-3), monocyte chemotactic
protein-5 (MCP-5), myeloperoxidase (MPO), myoglobin,
oncostatin-M (OSM), serum amyloid P-component (SAP),
serum glutamic oxaloacetic transaminase (SGOT), stem cell
factor (SCF), T-cell-specific protein, RANTES, thrombopoi-
etin (TPO), tissue factor (TF), tissue inhibitor of metallopro-
teinase 1 mouse (Timp-1 mouse), tumor necrosis factor alpha
(TNF-alpha), vascular cell adhesion molecule-1 (VCAM-1),
vascular endothelial growth factor A (VEGF-A), and von
Willebrand factor (vWF) by a multiplexed fluorescent bead-
based immunoassay (Luminex, Myriad RBM, Austin, Texas).
2.5. RNA Isolation, cDNA Synthesis, and Quantitative
Real-Time PCR of Adipose Tissue. Adipose tissue (AT) was
isolated from mice (for groups see above) and immediately
frozen with liquid nitrogen and stored at −80∘C until use.
RNA was isolated by a combination of Trifast (Peqlab,
Erlangen, Germany) and RNeasy Mini Kit (Qiagen, Hilden,
Germany). Respective tissue was homogenized with a
Precellys 24 (Peqlab, Erlangen, Germany) homogenizer in
the presence of Trifast, followed by 5min incubation on
ice and centrifugation at 4∘C and 12000×g for 10min. The
supernatant was mixed with 200𝜇L chloroform, followed by
10min incubation at room temperature. After centrifugation
at full speed for 15min, the upper phase was mixed with an
equal amount of 70% ethanol. The mix was loaded on an
RNeasy Mini spin column and RNA isolated according to
the manufacturer’s instructions. The RNA concentrations
were measured with a NanoDrop ND-1000 (Kisker-Biotech,
Steinfurt, Germany). The isolated RNA (500 ng, each) was
converted to cDNA using the iScript cDNA Synthesis Kit
(BioRad, Munich, Germany). The conditions for the reverse
transcription were as follows: 1 cycle at 25∘C for 5min; 1
cycle at 42∘C for 30min; 1 cycle at 85∘C for 5min. Relative
quantification of IL-1𝛽, TNF-𝛼, NLRP-3, and IL-18 was
performed by quantitative real-time PCR with the iQ SYBR
Green Supermix in duplets according to the manufacturer’s
instructions (BioRad, Munich, Germany). Per reaction, a
25 𝜇L mixture was used containing 12.5 𝜇L iQ SYBR Green
Supermix, 0.5 𝜇L forward and reverse primer (RPL32-
F: 5󸀠-TGGAGGTGCTGCTGATGTG-3󸀠; RPL32-R: 5󸀠-
GCGTTGGGATTGGTGACTCT-3󸀠 (product size: 127 bp);
IL-1𝛽-F: 5󸀠-TGGTGTGTGACGTTCCCATT-3󸀠; IL-1𝛽-: 5󸀠-
TCGTTGCTTGGTTCTCCTTG-3󸀠 (product size: 172 bp);
NLRP-3-F: 5󸀠-TCCAGCACCCAGGCTGTAAC-3󸀠; NLRP-
3-R: 5󸀠-TGCAGAGCAGGTGCTTCAGT-3󸀠 (product size:
189 bp); TNF-𝛼-F: 5󸀠-AGGGCTGTGGGACCTAAATGT-3󸀠;
TNF-𝛼-R: 5󸀠-ATGGGATGAGTATGGGGCAGC-3󸀠 (product
size: 199 bp); IL-18-F: 5󸀠-GCCGACTTCACTGTACAACCG-
3󸀠; IL-18-R: 5󸀠-GAGGGTCACAGCCAGTCCTC-3󸀠 (product
size: 182 bp)), 9.5𝜇L sterile water, and 2 𝜇L of the 1 : 5 diluted
complementary DNA template. A nontemplate control was
performed in each run. The conditions of the real-time
PCR (Mx3000P, Stratagene, Heidelberg, Germany) were
as follows: 1 cycle at 95∘C for 10min and then 40 cycles at
95∘C for 10 s, 59∘C for 10 s, and 72∘C for 10 s, followed by
a dissociation curve. The intron-spanning primers were
designed by using sequence information from the NCBI
database. The threshold cycle (Ct) values were normalized
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to the endogenous control (ribosomal protein L32, RPL32),
𝑛 = 3-4.The specificity of the primer pair products was tested
by melting curves and agarose (1.6%) gel electrophoresis.
2.6. RNA Isolation, cDNA Synthesis, and Quantitative Real-
Time PCR of Liver Tissue. The expression of the following
enzymes was investigated: ceramide synthase 2 (CerS2),
ceramide synthase 4 (CerS4), fatty acid elongase 1 (ELOVL1),
fatty acid elongase 3 (ELOVL3), alkaline ceramidase 2
(ACER2), serine palmitoyltransferase, long chain base
subunit 2 (SPTLC2), sphingomyelin phosphodiesterase 1 acid
lysosomal (SMPD1), and stearoyl-CoA desaturase (delta-
9-desaturase, SCD1). RNA isolation, cDNA synthesis, and
qPCR analysis were performed as described recently in detail
[28]. In brief, total RNAwas isolated from 10mg liver aliquots
using TRIzol reagent (Invitrogen, Karlsruhe, Germany), and
RNA concentration and purity were estimated from the
optical density at 260 and 280 nm (Infinite 200M microplate
reader, Tecan, Ma¨nnedorf, Switzerland). RNA integrity was
assessed by confirming intact bands corresponding to the
18S and 28S ribosomal RNA subunits using 1% agarose gel
electrophoresis. Following cDNA synthesis within one week
after RNA isolation using dT18 primer andM-MuLV Reverse
Transcriptase (MBI Fermentas, St. Leon-Rot, Germany),
qPCR runs were performed with a Rotorgene 2000 system
(Corbett Research, Mortlake, Australia) as described recently
in detail [28]. The used primers were as follows: ceramide
synthase 2-F: CAAAGCTGGACCAAGGTTCC, ceramide
synthase 2-R: GAGAGGGAGGCAGTGAGATC, ceramide
synthase 4-F: CTGTGGGTGTCCTTGTAGTCC, ceramide
synthase 4-R: TCCTCTGGCTTTGGTTTCTG, fatty acid
elongase 1-F: TCCCATCCCTTCTCCCAGCC, fatty acid
elongase 1-R: CCAGCCCTTTCAGCCTCCAG, fatty acid
elongase 3-F: AGACCTACCGGCTGTCCTCC, fatty acid
elongase 3-R: GAACCGAGTGAGCGTCCAGG, alkaline
ceramidase 2-F: AGCCCGCCATCAACAATA, alkaline
ceramidase 2-R: CCAGCAGAAGAGAGCCAGAG, serine
palmitoyltransferase, long chain base subunit 2-F: CCTGTC-
AGCAGCTCATACCA, serine palmitoyltransferase, long
chain base subunit 2-R: CACACTGTCCTGGGAGGAAT,
sphingomyelin phosphodiesterase 1, acid lysosomal-F: GCC-
AGTCAGCCGTCCATC, sphingomyelin phosphodiesterase
1, acid lysosomal-R: CCCAGAAGCAAGCCACAAG,
stearoyl-CoA desaturase (delta-9-desaturase)-F: CGTGGC-
TTCTTCTTCTCTCTCA, and stearoyl-CoA desaturase
(delta-9-desaturase)-R: CTTCTCGGCTTTCAGGTCAG.
All primer pairs were designed to have melting temperatures
of about 60∘C, and if possible, both primers of a primer
pair were designed to be located in different exons. Ct
values of target genes and reference genes were obtained
using Rotorgene Software 5.0 (Corbett Research). For
determination of relative expression levels relative quantities
were calculated using GeNorm normalization factor. In
order to calculate the normalization factor, all Ct values were
transformed into relative quantification data by using the
2
−ΔCt equation, and the highest relative quantities for each
gene were set to 1. From these values the normalization factor
was calculated as the geometric mean of expression data of
the three most stable out of six tested potential reference
genes (ATP5B, CANX, CYC1, EIF4, GAPDH, and RPS9).
Reference gene stability across samples from each tissue
and each cell line was determined by performing GeNorm
analysis [29]. After normalization of gene expression data
using the calculated GeNorm normalization factor, means
and SD were calculated from normalized expression data for
samples of the same treatment group.
2.7. Measurement of Circulating Fatty Acids and Ceramides.
Lipids were quantified by direct flow injection electro-
spray ionization tandem mass spectrometry (ESI-MS/MS)
in positive ion mode using the analytical setup and strategy
described previously [30]. In brief, plasma samples were
extracted according to the method by Bligh and Dyer [31]
in the presence of nonnaturally occurring lipid species used
as internal standards. A fragment ion of m/z 264 was
applied for sphingosine-based ceramides (Cer) and hexosyl-
ceramides (HexCer) with N-heptadecanoyl-sphingosine as
internal standard [32]. Fatty acid methyl ester was formed
by methanolic acetyl-chloride derivatization and extracted
with hexane. Total fatty acid (FA) analysis was carried out by
gas chromatography coupled to mass spectrometry (GC-MS)
[33].
2.8. Statistical Analysis. Two-way ANOVAs with Bonferroni
post hoc testing were performed in order to analyze dif-
ferences between treatments. For the analysis of FA and
ceramides a Bonferroni correction was applied with sig-
nificance levels of 𝑝 < 0.002 (fatty acids) and 𝑝 <
0.005 (ceramides). We present the proinflammatory panel
measured by multiplex ELISA as a heat map. To compare
the cytokine production between the groups we used a two-
way ANOVA with Bonferroni correction and set the new
significance cut-off at 𝑝 < 0.001. In order to calculate
the corrected 𝑝 value we divided 𝑝 < 0.005 by the
number of compared parameters. Furthermore, we calculated
percentage changes of the cytokine levels of the HFD groups
relative to the mean of the ST/S group. For the analysis of
the RT-PCR results from AT, the comparative Ct method
was used. Data are shown as 2(delta)(delta)Ct (ΔΔCt) that were
calculated by subtracting the mean ΔCt (Ct (reference gene)
−Ct (gene of interest)) of control sample from theΔCt of each
examined sample. Two-way ANOVA was used to compare
theΔCt values between the treatments.The statistical analysis
of hepatic mRNA expression was performed as a two-way
ANOVA on the relative mRNA levels calculated as described
above.
3. Results
3.1. Exercise Reduces Glucose Intolerance and Restricts Weight
Gain in HFD Mice. Diet and exercise had significant effects
on blood glucose (𝑝 < 0.01) after glucose challenge. Com-
pared to ST/S group blood glucose levels in the HFD/S group
were significantly higher at all-time points after glucose chal-
lenge (𝑝 < 0.001). Both types of exercise led to a significant
reduction of glucose intolerance in the HFD animals when
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Table 2: Effects of exercise on the plasma total fatty acid profiles of standard diet or HFD mice.
Fatty acid ST/S ST/ET ST/RT HFD/S HFD/ET HFD/RT
(𝜇mol/L) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD)
12:00 6.0 (0.50) 6.0 (0.50) 6.0 (0.30) 7.0 (2.00) 8.0 (2.00)a 8.0 (1.00)a
14:00 22.0 (3.00) 21.0 (2.00) 26.0 (3.00) 38.0 (7.00)a 46.0 (17.00)a 47.0 (10.00)a
15:00 9.0 (2.00) 9.0 (1.00) 11.0 (1.00) 6.0 (1.00) 7.0 (1.00) 7.0 (0.40)
16:00 1657000.0 (254.00) 1461000.0 (147.00) 1777000.0 (116.00) 2200.0 (431.00)a 2200.0 (281.00)a 2149000.0 (145.00)
16:01 254.0 (56.00) 224.0 (37.00) 279.0 (36.00) 176.0 (27.00)a 179.0 (42.00) 169.0 (14.00)a
17:00 12.0 (2.00) 11.0 (1.00) 13.0 (0.40) 17.0 (2.00)a 18.0 (2.00)a 18.0 (1.00)a
18:00 437.0 (49.00) 373.0 (31.00) 435.0 (14.00) 1368.0 (260.00)a 1400.0 (91.00)a 1374.0 (70.00)a
18:1 (n-9) 1174000.0 (177.00) 1081000.0 (141.00) 1333000.0 (91.00) 1669.0 (133.00)a 1711.0 (88.00)a 1694000.0 (221.00)
18:1 (n-7) 167.0 (17.00) 162.0 (18.00) 182.0 (11.00) 128.0 (14.00)a 133.0 (19.00) 121.0 (16.00)a
18:2 (n-6) 1664000.0 (269.00) 1494000.0 (132.00) 1811000.0 (66.00) 2290.0 (486.00)a 2318.0 (281.00)a 2328.0 (95.00)a
18:3 (n-3) 18.0 (5.00) 20.0 (2.00) 26.0 (3.00) 17.0 (4.00) 20.0 (8.00) 21.0 (5.00)
20:00 7.0 (2.00) 6.0 (1.00) 8.0 (1.00) 9.0 (2.00) 10.0 (3.00) 11.0 (2.00)
20:1 (n-9) 28.0 (11.00) 21.0 (2.00) 26.0 (3.00) 27.0 (7.00) 26.0 (6.00) 38.0 (9.00)
20:3 (n-6) 79.0 (5.00) 64.0 (6.00) 72.0 (9.00) 157.0 (62.00)a 147.0 (33.00)a 119.0 (32.00)
20:4 (n-6) 665.0 (47.00) 516.0 (80.00) 573.0 (74.00) 2005.0 (780.00)a 2143.0 (270.00)a 1720.0 (297.00)a
20:5 (n-3) 9.0 (2.00) 8.0 (1.00) 10.0 (1.00) 30.0 (10.00)a 36.0 (2.00)a 31.0 (4.00)a
22:4 (n-6) 11.0 (1.00) 9.0 (1.00) 11.0 (1.00) 15.0 (4.00) 15.0 (2.00)a 14.0 (1.00)
22:5 (n-3) 10.0 (1.00) 9.0 (1.00) 10.0 (2.00) 17.0 (5.00)a 19.0 (3.00)a 19.0 (3.00)a
22:6 (n-3) 162.0 (5.00) 121.0 (13.00) 137.0 (13.00) 576.0 (222.00)a 594.0 (47.00)a 513.0 (116.00)a
ST: standard diet, HFD: high fat diet, S: sedentary, ET: endurance training, and RT: resistance training. SD: standard deviation. For each group 𝑛 = 5. aST fed
groups versus corresponding HFD groups (𝑝 < 0.002).
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Figure 1: Area under the curve (AUC) of mean blood glucose
(mg/dL) of mice fed standard chow or a high fat diet following
an intraperitoneal glucose challenge. ST: standard diet, HFD: high
fat diet, S: sedentary, ET: endurance training, and RT: resistance
training. SD: standard deviation. For each group 𝑛 = 5. ∗∗∗𝑝 <
0.001, comparison within HFD groups: sedentary versus ET or RT
and ET versus RT.
compared with the sedentary group. However, the effect was
more pronounced after ET (𝑝 < 0.001; Figure 1). Mice fed the
HFD gained significantly more weight than the mice fed the
ST diet (𝑝 < 0.001, Figure 2(a)). Within the high fat group,
both ET (𝑝 < 0.05) and RT (𝑝 < 0.001) attenuated the weight
gain when compared with the sedentary group. VO
2
max
change was measured at baseline before exercise commenced
as well as after 10 weeks on exercise. The percent changes
in VO
2
max for each diet and exercise group are shown in
Figure 2(b). ET but not RT led to significant increases of
VO
2
max in both ST and HFD groups (𝑝 < 0.001).
3.2. Ceramide Profiles Are Affected by Exercise. The HFD
significantly increased most of the total fatty acids and
ceramides in plasma of mice from HFD/S group (𝑝 < 0.005;
Tables 2 and 3). 13 out of 19 fatty acids analyzedwere increased
while 6were unaffected.Neither ETnorRTwas able to reduce
significantly any fatty acid compared to the enhanced levels of
sedentary mice. Eight out of 10 ceramides analyzed increased
significantly in plasma from HFD/S mice compared to ST/S
mice (Table 3). ET and RT affected ceramide levels slightly
different in HFD mice. While ET decreased Cer d23:0 and
d24:1, RT was followed by a significant decrease of Cer d24:1
and HexCer d24:1 (𝑝 < 0.005; Table 3).
3.3. Exercise Reduces Hepatic Expression of CerS4 and SPTLC2
in HFDMice. Endurance training significantly decreased the
relative mRNA levels of CerS2, ELOVL1, and ELOVL3 as well
as SMPD1 (𝑝 < 0.05) in comparison with the sedentary
ST group (Figures 5(a), 5(c), 5(d), and 5(g)). Furthermore,
ET increased the relative mRNA level of CerS2 (𝑝 < 0.05)
in the HFD in comparison to the corresponding ST fed
mice. In contrast, ELOVL3 was strongly reduced in the ET
group due to the HFD feeding. RT had no effect on CerS2
and ELOVL1 expression. However, ELOVL3 was reduced by
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Table 3: Ceramide profiles of mice following a standard diet or HFD fed mice for 14 weeks.
Ceramide ST/S ST/ET ST/RT HFD/S HFD/ET HFD/RT
(𝜇mol/L) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD)
d18:1/16:0 0.253 (0.027) 0.228 (0.020) 0.255 (0.044) 0.749 (0.182)a 0.723 (0.097)a 0.659 (0.119)a
d18:1/18:0 0.039 (0.027) 0.051 (0.029) 0.057 (0.027) 0.192 (0.096)a 0.201 (0.058)a 0.174 (0.059)a
d18:1/20:0 0.079 (0.004) 0.062 (0.026) 0.073 (0.019) 0.483 (0.202)a 0.398 (0.113)a 0.439 (0.145)a
d18:1/22:0 0.677 (0.089) 0.477 (0.118) 0.576 (0.103) 2.672 (1.120)a 2.060 (0.286) 2.404 (1.001)a
d18:1/23:0 0.350 (0.046) 0.373 (0.070) 0.397 (0.033) 0.627 (0.149)a 0.462 (0.052)∗ 0.521 (0.095)
d18:1/24:1 1.722 (0.065) 1.261 (0.097) 1.323 (0.108) 2.782 (0.939) 1.815 (0.376)∗ 1.819 (0.284)∗
d18:1/24:0 1.027 (0.185) 0.819 (0.119) 0.949 (0.142) 1.035 (0.163) 0.814 (0.083) 0.950 (0.155)
HexCer d18:1/16:0 0.274 (0.062) 0.239 (0.030) 0.252 (0.019) 0.860 (0.197)a 0.791 (0.142)a 0.725 (0.093)a
HexCer d18:1/24:1 0.815 (0.126) 0.698 (0.063) 0.806 (0.082) 1.466 (0.307)a 1.398 (0.223)a 1.092 (0.155)∗
ST: standard diet, HFD: high fat diet, S: sedentary, ET: endurance training, and RT: resistance training. SD: standard deviation. For each group 𝑛 = 5. aST
fed groups versus corresponding HFD groups (𝑝 < 0.005), ∗comparison within ST groups or HFD groups, sedentary versus ET or RT (𝑝 < 0.005): HexCer:
hexosylceramide.
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Figure 2: Percentage change in body weight (a) and VO
2
max (b) of untrained and trained mice following either a ST diet or a HFD for 10
weeks. ST: standard diet, HFD: high fat diet, S: sedentary, ET: endurance training, and RT: resistance training. ∗∗∗𝑝 < 0.001, ∗𝑝 < 0.05.
RT only in the ST group (Figures 5(c) and 5(d)). ELOVL1
and ELOVL3 mRNA expression decreased in the sedentary
group due to the high fat diet. SCD1 and ACER2 were not
significantly changed in the ST groups.However, we observed
a trend towards a reduction of mRNA expression due to
exercise in the HFD groups that did not reach statistical
significance (Figures 5(e) and 5(h)). The comparison within
the HFD groups revealed that ET significantly reduced
CerS4 and SPTLC2 mRNA. Resistance training had a similar
effect on SPTLC2 but did not reach significance for CerS4
(Figure 5(f)).
3.4. Exercise Reverses HFD-Induced Alterations of Proin-
flammatory Cytokines. After exposure to HFD a number of
cytokines increased in sedentary animals. Plasma concentra-
tions of eotaxin, haptoglobin, MCP-1, MCP-3, MPO, CD40,
KC/GRO, SAP,VCAM-1, vWF,Timp-1, IP-10, IL-18, andMIP-
1𝛾 were significantly increased in HFD/S group compared to
the ST/S (𝑝 < 0.001). Alterations of some cytokines could
be reversed by exercise intervention. Again, exercise regimes
differently affect cytokine expression in the HFD groups
(Figure 3(b)). While ET significantly reduced cytokine levels
of MIP-1𝛾, RT was followed by a significant reduction of
CD40, IL-18,MIP-1𝛾, andTimp-1 (𝑝 < 0.001). In addition, we
show in Figure 3(a), as a supplementary graph, the percentage
change of selected cytokines levels after both ET andRT in the
HFDgroupswhich represent themost prominent effects.This
should illustrate the effect of exercise on the cytokine level of
high fat diet fed mice. Notably, mice fed the HFD showed a
decrease of plasma immunoglobulin A (𝑝 < 0.001) which
was not affected by any exercise intervention.
3.5. Exercise Differently Downregulates the Expression of
Inflammatory Markers in Adipose Tissue. Feeding the HFD
was followed by a significant increase of IL-18, TNF-𝛼, and
NLRP-3mRNA expression in AT, while the enhancedmRNA
expression of IL-1𝛽 did not reach significance (Figures 4(a)–
4(d)). The two types of exercise intervention affected the
inflammatory markers differently. ET was accompanied by a
significant reduced expression of TNF-𝛼 and IL-1𝛽 compared
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Figure 3: (a) Percent change in cytokine levels in the high fat groups relative to the ST/S group. Exercise, in particular resistance training,
showed the tendency to partially reverse the HFD-induced increase in several cytokines. For each individual animal the percentage change in
cytokine level relative to themean cytokine levels of the ST/S groupwas calculated.Theblack bars represent the percentage changes in cytokine
production after HFD/S in comparison to the mean of the ST/S group. (b) Heat map summarizing cytokine production in plasma samples of
mice fed either a ST diet or a HFD that were subjected to endurance and resistance training, as well as sedentarism. Each column shows the
mean of six animals per group.The scale represents the𝑍-scores from the log2-transformed values of each cytokine (red indicates𝑍 > 0, green
indicates 𝑍 < 0, and black indicates 𝑍 = 0). ST: standard diet, HFD: high fat diet, S: sedentary, ET: endurance training, and RT: resistance
training. For each group 𝑛 = 6. MCP-5: monocyte chemotactic protein-5, M-CSF: macrophage colony-stimulating factor-1, mEGF: epidermal
growth factormouse, ApoA-I: apolipoproteinA-I, VEGF-A: vascular endothelial growth factorA,mGCP-2: granulocyte chemotactic protein-
2 mouse, IL-1𝛼: interleukin 1 alpha, MIP-1𝛽: macrophage inflammatory protein-1𝛽, VCAM-1: vascular cell adhesion molecule-1, MIP-1𝛾:
macrophage inflammatory protein-1 gamma, SCF: stem cell factor, mCRP: C-reactive protein mouse, SAP: plasma amyloid P-component,
MDC: macrophage-derived chemokine, FGF-basic: fibroblast growth factor basic, TF: tissue factor, KC/GRO: growth-regulated 𝛼 protein,
vWF: vonWillebrand factor, MMP9: matrix metalloproteinase 9, MPO: myeloperoxidase, MCP-3: monocyte chemotactic protein 3, Timp-1:
tissue inhibitor of metalloproteinase 1 mouse, and IP-10: interferon gamma-induced protein 10.
to HFD/S group. In contrast, RT significantly reduced only
the NLRP-3 expression (Figure 4(d)). A secondary finding
was that both exercise treatments were effective in enhancing
IL-18 expression in AT of ST fed mice.
4. Discussion
We showed that HFD-induced obesity was associated with
a substantial increase in body weight, a decrease of physical
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Figure 4: Adipose tissue mRNA expression of IL-1𝛽 (a), TNF-𝛼 (b), IL-18 (c), and NLRP-3 (d) in sedentary and exercised groups of animals
fed a standard or a high fat diet. Delta delta Ct (ΔΔCt) values were calculated by subtracting the mean ΔCt of ST/S (control) from the ΔCt
of each examined sample. Statistical comparison was performed on ΔCt of each group. Data are shown as log2 (2ΔΔCt) values. A: comparison
between ST diet groups and corresponding HFD group (𝑝 < 0.05), #: comparison between sedentary HFD group and the exercised HF
groups, ST: standard diet, HFD: high fat diet, S: sedentary, ET: endurance training, and RT: resistance training.
performance, elevated levels of serum ceramides and fatty
acids, both a local, in AT, and a systemic inflammatory
response, and finally glucose intolerance. Both training
interventions, endurance as well as resistance exercise, were
effective in reversing or in attenuating the diet-induced
glucose intolerance. However ET reduced blood glucose
more efficiently than RT (𝑝 < 0.001) probably due to higher
energy expenditure in the ET group. It is speculated that
the exercise effect might be mediated via metabolic and
inflammatory pathways as indicated by decreased levels of
serum ceramides and reduced levels of tissue and serum
inflammatory markers.
Obesity-associated tissue inflammation is assumed to be
an important factor in the activation of the innate immune
system leading to a systemic chronic low grade inflamma-
tion. It has been suggested that the starting point for AT
inflammation might be the cell stress-associated accumula-
tion of metabolites which have been shown to dramatically
increase in response to HFD feeding [34]. In this regard,
ceramides may represent a potential upstream initiating
event for obesity-induced inflammation [18]. Current data
demonstrated that high fat feeding induced an increase of
several ceramides in serum, an observation that is in line with
previous studies [19]. Likewise, ceramide transported in LDL
has been shown to be elevated in the plasma of obese patients
with type 2 diabetes [35]. Incubating cultured myotubes
with reconstituted low density lipoprotein ceramide 24:0
promoted ceramide accrual in cells and was accompanied
by reduced insulin-stimulated glucose uptake. Moreover, in
lean mice the infusion of LDL-ceramide reduced insulin-
stimulated glucose uptake, and this was due to impaired
insulin action specifically in skeletal muscle [35]. Ceramide
seems to induce insulin resistance by inhibiting insulin
signal transduction, principally at Akt [36]. Ceramide is
also postulated to activate proinflammatory pathways in
macrophages, perhaps via amplification of TLR 4-mediated
inflammation [18]. Therefore, it has been suggested that
changes in plasma long chain ceramidesmight link the effects
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Figure 5: Continued.
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Figure 5: RelativemRNAof genes involved in ceramide biosynthesis pathway in liver of exerciseHFD and ST fedmice. A detailed description
of the calculation of the relative mRNA levels can be found in Material and Methods. Briefly, all Ct values were transformed into relative
quantification data by using the 2−ΔCt equation, and the highest relative quantities for each gene were set to 1. (a) CerS2: ceramide synthase
2, (b) CerS4: ceramide synthase 4, (c) ELOVL1: fatty acid elongase 1, (d) ELOVL4: fatty acid elongase 3, ACER2: alkaline ceramidase 2, (f)
SPTLC2: serine palmitoyltransferase, long chain base subunit 2, (g) SMPD1: sphingomyelin phosphodiesterase 1 (acid lysosomal), and (h)
SCD1: stearoyl-CoA desaturase-1. HFD: high fat diet, ST: standard diet, S: sedentary, ET: endurance training, and RT: resistance training.
A: comparison between ST diet groups and corresponding HFD group (𝑝 < 0.05); #: comparison between sedentary HFD group and the
exercised HF groups.
of HFD on the inflammatory status of adipose tissue. We
did not determine macrophage phenotype in adipose tissue
but showed that an increased expression of TNF-𝛼, IL-18,
and NLRP-3 which was detected in adipose tissue of HFD/S
group might indicate adipose tissue inflammation. These
findings are in line with previous studies which found an
increased inflammatory status in AT in response to chronic
high fat feeding [34, 37]. Interestingly, both exercise regimes
differently affected expression of inflammatory markers in
AT. While ET significantly reduced the expression of TNF-𝛼,
IL-1𝛽, and IL-18, RT reduced NLRP-3 expression. Thereby, a
reduced expression of TNF-𝛼 and IL-1𝛽might be interpreted
as a reduction of macrophage and lymphocyte activation
[10]. Although we did not determine caspase activity, the
reduced expression of IL-1𝛽 might represent a decrease in
the maturation of IL-1𝛽 by a decrease in NLRP-3 dependent
caspase 1 activity [18, 38]. However, a reduction of caspase
1 activity has been shown to be linked with lower levels of
ceramides in serum, which has been demonstrated in our
study after the exercise interventions [38]. Therefore, our
study suggests that a starting point for the anti-inflammatory
effects of exercise trainingmight be the reduction in ceramide
levels. These results are in line with previously published
research that demonstrated the essential involvement of
ceramides in the development of insulin resistance [39, 40].
Exercise significantly decreased Cer d18:1/23:0 and d18:1/24:1
in the HFD/ET group and d18:1/24:1 andHexCer d18:1/24:1 in
the HFD/RT group when compared to the HFD/S group.The
ceramides measured are secreted by the liver and bound to
lipoproteins. It has been shown that Cer 24:1 and 24:0 make
up about 80% of all measured plasma ceramides. Ceramides
like reconstituted low density lipoprotein ceramide 24:0 were
found to increase TNF-𝛼, IL-1𝛽, IL-6, and MCP-1 in vitro
and to induce insulin resistance in lean mice [35]. It is
therefore assumed that the exercise-induced reduction of
plasma long chain ceramides is at least one reason for the
reduced expression of inflammatory markers in serum and
AT as well as the increased glucose tolerance.
Because of the reduced levels of ceramides in plasma, we
measured whether exercise affects the expression of genes
involved in the synthesis of ceramides. CerS2 and ELOVL1
have been shown to be essential for the synthesis of Cer
d24:0 and Cer d24:1 [41]. The hepatic mRNA expression
levels of CerS2 and CerS4 do not change significantly in the
sedentary HFD mice groups which might suggest adequate
substrate availability under condition of our HFD protocol.
ELOVL1 and ELOVL3 decreased significantly in the HFD/S
group in comparison with the ST/S group. Since the HFD
feeding led to a significant increase in long chain FAs, this
downregulation of elongases might indicate a feedback loop
mechanism where a high pool of FA downregulates mRNA
expression. In murine hepatocytes, the expression of CerS4
is far below that of CerS2, which is the most abundantly
expressed ceramide synthase in mammals. CerS2 and CerS4
share some substrate specificity; for example, CerS4 utilizes
C18-C22 FA, whereas CerS2 utilizes C20-C26 FA [42, 43].
Furthermore, the synthesis rate of CerS in vitro has been
shown to be dose-dependent and that ceramide synthesis
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is governed by the availability of FA [44, 45]. In addition,
our results showed that SPTLC2 expression was significantly
reduced by exercise which might also point towards a decline
of available FA for ceramide synthesis. Therefore, we can
speculate that exercise affects blood ceramide profile mostly
through an alteration of substrate availability for ceramide
synthesis rather than a change in expression of gene involved
in the ceramide pathway.
Another reason for the reduced expression of inflam-
matory markers in serum and AT might be the effects of
both exercise and diet on the expression of IL-18. IL-18 is
generally considered a proinflammatory cytokine, associated
with obesity and insulin resistance. Alterations in IL-18might
have been responsible for both the downregulation of glucose
tolerance in HFD/S group and the increased glucose sensitiv-
ity after exercise training. These assumptions are supported
by previous studies which found that obese individuals had
higher IL-18 mRNA content in the abdominal adipose tissue
than nonobese subjects and that exercise training lowered the
elevated IL-18mRNA levels in obese subjects [46]. Activation
of the NLRP-3 inflammasome in course of diet-induced
obesity in mice led to an increase in IL-18 secretion and was
shown to affect insulin signaling [18]. In addition, it has been
shown that IL-18 mRNA and plasma IL-18 correlated with
insulin resistance, suggesting that training-induced reduc-
tion in IL-18 expression may be a contributing mechanism
to improve insulin sensitivity after training [18, 46, 47].
We found that IL-18 mRNA expression in AT was
increased in all high fat groups but was not changed by
exercise. The levels of plasma IL-18, however, were signif-
icantly increased in the HFD/S group and were reduced
by endurance as well as by resistance training. This was
associated with improved glucose tolerance in the exercised
groups [46].The results of our study therefore suggest that the
reduction of NLRP-3 levels in AT was not effective enough in
reducing IL-18 mRNA expression in AT. However, we spec-
ulate that it affected posttranslational modification leading
to a reduced maturation of IL-18 protein in AT or a reduced
mobilization of IL-18 into the blood stream. The role of IL-
18 during development of obesity seems to be ambivalent
as it has been shown that deficiency of either IL-18 or IL-18
receptor triggers obesity and hyperinsulinemia in mice and
that treatment with recombinant IL-18 reversed these effects
[47]. Additionally, IL-18 elevated adenosinemonophosphate-
activated protein kinase in skeletal muscle which is known
to increase energy expenditure and endurance in mice [48,
49]. These studies indicate that IL-18 might play an essential
role in metabolic regulation and exercise adaptation. In the
current study the expression of IL-18, in AT, was significantly
increased in the exercised standard fed mice when compared
with the ST/S animals. Additionally, we did not detect
elevated glucose levels in the exercising ST groups. These
results suggest that the role of IL-18 in AT is that of a
metabolic key cytokine which might also be involved in the
adaptation to exercise.
In addition to IL-18, exercise was effective in reducing
TNF-𝛼 mRNA expression which might represent another
pathway of action. Regarding the connection between inflam-
mation and insulin resistance, it is known that TNF-𝛼 induces
insulin resistance in vitro and in mice [50]. However, in
contrast to IL-18 a decrease of TNF-𝛼 was found in AT after
exercise while no changes of peripheral TNF-𝛼were detected.
The localized inflammatory environment inside the
adipose tissue seemed to have systemic consequences as
reflected by enhanced levels of several proinflammatory
serum cytokines. A cluster of proinflammatory cytokines
increased in the HFD/S group might indicate a state of
chronic low grade inflammation [17]. Thereby, notable
increases of CD40 might be the result of an activation of
lymphocytes, while cytokines like IL-18, MIP-1𝛾, and Timp-1
might point towards an increased activation of macrophages
[8]. Both exercise types reversed the diet-induced increase
of some of these cytokines. While RT mainly affected CD40,
IL-18, MIP-1𝛾, and Timp-1 expression, ET effectively reduced
MIP-1𝛾. Since both exercise types reduced body weight, we
cannot exclude the possible confounding effect of this weight
loss and potential lower body fat content on the reduction
of inflammatory markers. A major limitation of this study is
that our HFD model contained 34% lipids by weight, which
is a moderate challenge. However, we propose that exercise
diminishes both lymphocyte and macrophage activity which
is in accordance with previously published data [10].
Taken together, we show that HFD-induced obesity is
accompanied by an increase of ceramides, activation of
inflammasome in AT, and a secretion of several proinflam-
matory cytokines including IL-18 that all are known to affect
glucose sensitivity. Both ET and RT are effective therapeutic
strategies to improve bothmetabolic dysfunction and inflam-
matory status resulting in an improved glucose tolerance.
However, the identification of definitive molecular targets for
both training regimes, which seem to address slightly differ-
ent signaling pathways, has to be elucidated in future studies.
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